A Randomized Control Trial Phase (IIIa) Unicentric, Placebo Controlled, Double-Blinded Study to confirm the Efficacy and Safety of "Effects of topical Alendronic Acid on alveolar bone remodeling after tooth extraction: a pilot study".
Latest Information Update: 26 Sep 2024
At a glance
- Drugs Alendronic acid (Primary)
- Indications Periodontal disorders
- Focus Registrational; Therapeutic Use
- Acronyms XEOLAS
- Sponsors Xeolas Pharmaceuticals
Most Recent Events
- 19 Sep 2024 Planned End Date changed from 30 Dec 2023 to 20 Oct 2024.
- 19 Sep 2024 Planned primary completion date changed from 30 Dec 2023 to 20 Oct 2024.
- 19 Sep 2024 Status changed from recruiting to active, no longer recruiting.